Covid 19

Kerala Has Least Covid Antibodies, Madhya Pradesh Has Highest

The Union Health Ministry shared the findings of the serosurvey (blood serum test) conducted by ICMR across 70 districts of India.

At least two-third of the population surveyed in 11 states were found to have developed coronavirus antibodies, according to the findings of a serosurvey by the Indian Council of Medical Research (ICMR) done between June 14 and July 6.

Madhya Pradesh leads the chart with 79 percent seroprevalence while Kerala is at the bottom with 44.4 per cent. Seroprevalence in Assam is 50.3 per cent and Maharashtra is 58 per cent.

On Wednesday, The Union Health Ministry shared the findings of the fourth round of national serosurvey conducted by the ICMR across 70 districts of India.

Also read : Kerala Now Accounts For 50% Of All New Covid Cases In India, Worried Centre Intervenes

Seroprevalence was found to be 76.2 per cent among the surveyed population in Rajasthan, 75.9 per cent in Bihar, 75.3 per cent in Gujarat, 74.6 per cent in Chhattisgarh, 73.1 per cent in Uttarakhand, 71 per cent in Uttar Pradesh, 70.2 per cent in Andhra Pradesh, 69.8 per cent in Karnataka, 69.2 in Tamil Nadu and 68.1 per cent in Odisha.

The Health Ministry has advised states and Union Territories to conduct seroprevalence of their own in consultation with the ICMR to ensure that those studies follow a standardized protocol.

The serosurveys can be used as an evidence-based guide for public health response to COVID-19.

“The national sero-survey by ICMR was designed to capture the extent of the spread of Covid infection at the national level. Therefore, the national serosurvey results do not reflect the heterogeneity of seroprevalence between districts and even between states,” a statement said.

 

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.

Related posts